Qiagen NV
QGEN: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$38.00 | Zjkyx | Czkmthvmc |
Qiagen Earnings: Small Increases on 2024 Outlook Following Solid Operating Results
Qiagen's second-quarter results mildly exceeded expectations, and we've slightly raised our 2024 assumptions, although not enough to change our fair value estimate. Also, while we still give Qiagen a no-moat rating, we recognize that operations have improved substantially in recent years, even beyond the pandemic, and we expect Qiagen to remain economically profitable throughout our five-year forecast period.